Results of the 2006 Innsbruck International Consensus Conference on Intraperitoneal Chemotherapy in Patients with Ovarian Cancer Journal Article


Authors: Marth, C.; Walker, J. L.; Barakat, R. R.; Casado, A.; Gadducci, A.; Miller, B.; Odicino, F.; Pujade-Lauraine, E.; Sehouli, J.; Tropé, C.; Wenzel, L.; Zeimet, A. G.
Article Title: Results of the 2006 Innsbruck International Consensus Conference on Intraperitoneal Chemotherapy in Patients with Ovarian Cancer
Abstract: In February 2006, the International Consensus Conference on Intraperitoneal Chemotherapy in Ovarian Cancer Patients in provided the first worldwide consensus after the National Cancer Institute issued an announcement encouraging the treatment of advanced ovarian cancer with anticancer drugs after surgery, including intraperitoneal (IP) therapy. At that conference, a consensus was obtained on important questions regarding the standard of care in IP therapy for patients with ovarian cancer. © 2007 American Cancer Society.
Keywords: cancer chemotherapy; cisplatin; interferon; unspecified side effect; conference paper; gemcitabine; paclitaxel; topotecan; drug megadose; antineoplastic agent; ovarian neoplasms; carboplatin; multiple cycle treatment; nephrotoxicity; ovary cancer; erythropoietin; antineoplastic combined chemotherapy protocols; cancer research; docetaxel; cytokine; austria; consensus development; platinum derivative; ca 125 antigen; infusions, parenteral; radioactive material; international cooperation; colony stimulating factor
Journal Title: Cancer
Volume: 109
Issue: 4
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 2007-02-15
Start Page: 645
End Page: 649
Language: English
DOI: 10.1002/cncr.22467
PUBMED: 17238177
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 14" - "Export Date: 17 November 2011" - "CODEN: CANCA" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Richard R Barakat
    629 Barakat